Correlation Between ZyVersa Therapeutics and Cns Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ZyVersa Therapeutics and Cns Pharmaceuticals, you can compare the effects of market volatilities on ZyVersa Therapeutics and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Cns Pharmaceuticals.

Diversification Opportunities for ZyVersa Therapeutics and Cns Pharmaceuticals

0.57

Correlation Coefficient

ZyVersa Therapeutics  Cns Pharmaceuticals

Very weak diversification

The 3 months correlation between ZyVersa and Cns is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Cns Pharmaceuticals go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and Cns Pharmaceuticals

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Cns Pharmaceuticals. In addition to that, ZyVersa Therapeutics is 2.01 times more volatile than Cns Pharmaceuticals. It trades about -0.16 of its total potential returns per unit of risk. Cns Pharmaceuticals is currently generating about -0.08 per unit of volatility. If you would invest  14.00  in Cns Pharmaceuticals on August 30, 2024 and sell it today you would lose (2.00) from holding Cns Pharmaceuticals or give up 14.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

ZyVersa Therapeutics  vs.  Cns Pharmaceuticals

ZyVersa Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Cns Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with ZyVersa Therapeutics and Cns Pharmaceuticals

The main advantage of trading using opposite ZyVersa Therapeutics and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.

The idea behind ZyVersa Therapeutics and Cns Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.